Insider Trading & Ownership - Amado Rafael

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Amado Rafael
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-08-02
Sale
2022-08-02
5:40 pm
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
2,000$11.97$23,940540,257
(Direct)
View
2022-07-05
Sale
2022-07-06
4:16 pm
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
2,000$11.44$22,880542,257
(Direct)
View
2022-06-21
Sale
2022-06-22
4:47 pm
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
2,000$11.18$22,360544,257
(Direct)
View
2022-05-19
Sale
2022-05-19
5:40 pm
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
11,500$7.3993$85,092546,257
(Direct)
View
2022-03-15
Sale
2022-03-17
5:59 pm
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
5,169$7.709$39,848320,119
(Direct)
View
2021-10-01
Sale
2021-10-04
5:55 pm
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
11,507$24.35$280,185323,928
(Direct)
View
2021-03-15
Sale
2021-03-17
5:01 pm
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
2,798$38.05$106,471110,035
(Direct)
View
2020-10-07
Sale
2020-10-08
5:10 pm
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
16,538$39.4$651,515111,677
(Direct)
View
2020-10-01
Sale
2020-10-02
4:40 pm
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
9,752$36.37$354,662128,215
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-17
Option Award
2024-06-18
4:12 pm
N/A
2034-06-16
Poseida Therapeutics Inc.PSTXAmado Rafael
Director
47,000$086,300
(Direct)
View
2024-04-03
Exercise
2024-04-05
5:47 pm
N/A
N/A
Zai Lab LtdZLABAmado Rafael
See Remarks
5,391$039,705
(Direct)
View
2024-04-03
Exercise
2024-04-05
5:47 pm
N/A
N/A
Zai Lab LtdZLABAmado Rafael
See Remarks
5,391$15.939,705
(Direct)
View
2024-04-01
Option Award
2024-04-03
9:43 pm
N/A
2034-04-01
Zai Lab LtdZLABAmado Rafael
See Remarks
198,233$0198,233
(Direct)
View
2023-12-29
Exercise
2024-01-03
7:26 pm
N/A
N/A
Zai Lab LtdZLABAmado Rafael
See Remarks
42,000$0106,637
(Direct)
View
2023-05-01
Option Award
2023-05-02
4:14 pm
N/A
2033-04-30
Poseida Therapeutics Inc.PSTXAmado Rafael
Director
94,500$094,500
(Direct)
View
2023-04-03
Option Award
2023-04-05
4:05 pm
N/A
2033-04-03
Zai Lab LtdZLABAmado Rafael
See Remarks
134,781$0134,781
(Direct)
View
2022-12-30
Option Award
2023-01-03
4:10 pm
N/A
2032-12-30
Zai Lab LtdZLABAmado Rafael
See Remarks
309,700$0309,700
(Direct)
View
2022-10-07
Tax Withholding
2022-10-11
4:35 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D
8,464$11.83541,946
(Direct)
View
2022-10-07
Option Award
2022-10-11
4:35 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D
19,120$0541,946
(Direct)
View
2022-10-03
Tax Withholding
2022-10-05
4:02 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D
8,968$11.06531,290
(Direct)
View
2022-03-23
Option Award
2022-03-25
5:52 pm
N/A
2032-03-23
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
605,947$0926,066
(Direct)
View
2021-05-18
Option Award
2021-05-20
5:22 pm
N/A
N/A
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
200,534$0335,435
(Direct)
View
2021-03-26
Option Award
2021-03-30
4:47 pm
N/A
2031-03-26
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
117,231$0227,266
(Direct)
View
2020-03-18
Option Award
2020-03-20
4:37 pm
N/A
2030-03-17
Allogene Therapeutics Inc.ALLOAmado Rafael
EVP of R&D and CMO
140,400$0245,562
(Direct)
View